Safety and Efficacy of Two-step Radical Prostatectomy
NCT05722392
Summary
The goal of this observational study is to learn about the safety and efficacy of two-step radical prostatectomy in the treatment of low- to intermediate-risk prostate cancer patient with enlarged prostate and severe benign prostatic hyperplasia. The main question it aims to answer are: 1. Whether two-step prostatectomy is safe enough to decrease the surgical difficulty of these patients? 2. Whether the oncologic control is promising?
Eligibility
Inclusion Criteria: 1. Diagnosed as prostate cancer pathologically by prostate biopsy 2. Evaluated as localized prostate cancer by imaging studies 3. Prostate volume\>70mL evaluated by transrectal ultrasonography or multi-parametric magnetic resonance imaging 4. Gleason score≤ 4+3=7 5. Preoperative PSA\<20ng/mL 6. Estimated survival\> 10 years; 7. Informed consent is obtained from the patient Exclusion Criteria: 1. The patient has received other therapy including radical radiotherapy, transurethral resection of the prostate, cryoablation, HIFU, etc. 2. Any contraindication of surgery or anaesthesia
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05722392